International Day of Medical Physics
That the Parliament welcomes the first-ever International Day of Medical Physics on 7 November 2013; recognises what it sees as the valuable role played by those professionals engaged in this field in the NHS in Scotland, and considers that, with the growing use of radiotherapy and investigations involving emissions, their role is expanding and that this international recognition is overdue.
Genetic Testing for Prostate Cancer
That the Parliament recognises the Movember campaign, which highlights the significant mortality rate from prostate cancer and the difficulty in predicting which early cancers require radical intervention as opposed to watchful waiting; acknowledges what it considers the inadequacy of Prostate Specific Antigen (PSA) as a predictive or screening tool; welcomes the research by a UK/US team, led by Dan Berney, on CCP Score, which it considers is a novel genetic test for prostate cancer; notes that the team has developed an expression signature composed of 31 cell cycle progressions and 15 housekeeper genes; understands that an expression score (Prolaris score) was derived as the mean of all cell cycle progression genes and that the signature was tested at disease diagnosis in two conservatively managed cohorts (N=337 and 349) after radical prostatectomy in two cohorts from the United States (N=366 and 413) and after external beam radiation therapy (N=141); notes that all studies were retrospective; understands that the CCP signature was a highly significant predictor of outcome in all five studies; also understands that, in conservatively managed patients, the Prolaris score was the dominant variable for predicting death from prostate cancer; believes that, in all five studies, the HR per unit change in the Prolaris score was remarkably similar, ranging from 1.89 to 2.92, indicating that the effect size for the Prolaris score is robust in terms of clinical setting and patient composition, and hopes that what it considers this innovative tool will now be examined further in prospective studies.
Welcoming the Appointment of Dr Avinash Kanodia
That the Parliament welcomes the appointment of Dr Avinash Kanodia, a consultant radiologist with NHS Tayside, who will officially become the Scottish Adult Neuro-Oncology Network clinical lead on 4 November 2013 and thanks the current lead clinician, Professor Roy Rampling, for his leadership in continuing the development of what it considers this important Scottish managed clinical network in brain and central nervous system tumours.